Ribosomal protein L22-like1 (RPL22L1) mediates sorafenib sensitivity via ERK in hepatocellular carcinoma.

Cell Death Discov · 2022 · PMC9381560 · PMID 35973992

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

We also observed RPL22L1 showed an increasing trend along with tumor grades in TCGA-LIHC cohort (Fig. 1D ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.